At NINGBO INNO PHARMCHEM CO.,LTD., we provide essential chemical building blocks that drive innovation across various scientific fields. Z-Glu-OH, identified by CAS number 1155-62-0, is a key protected amino acid derivative with broad applications in biochemical research and pharmaceutical development.

In the realm of biochemical research, Z-Glu-OH serves as a valuable tool for scientists investigating complex biological processes. As a protected form of glutamic acid, it allows for the precise construction of peptides and other biomolecules. Researchers can utilize Z-Glu-OH in experiments aimed at understanding enzyme kinetics, protein-ligand interactions, and cellular signaling pathways. The reliability and purity of Z-Glu-OH are crucial for obtaining accurate and reproducible results in these sensitive studies. Many academic and industrial labs choose to buy Z-Glu-OH for its consistent performance in intricate experimental setups.

For pharmaceutical development, Z-Glu-OH is an indispensable intermediate. Its carbobenzyloxy (Z) protecting group shields the amino terminus, enabling controlled peptide chain elongation – a critical step in synthesizing peptide-based drugs. These drugs are increasingly important for treating conditions ranging from neurological disorders to metabolic diseases due to their specificity and efficacy. The market for Z-amino acid for peptide synthesis, including Z-Glu-OH, is robust, driven by the continuous demand for novel therapeutics. Understanding the pricing of Z-Glu-OH and its availability from trusted suppliers is vital for R&D project planning.

The versatility of Z-Glu-OH also extends to potential applications in drug delivery systems, where its properties can be harnessed to enhance the transport and bioavailability of active pharmaceutical ingredients. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying high-quality Z-Glu-OH, ensuring that researchers and developers have access to the critical components needed to advance scientific discovery and bring life-changing pharmaceuticals to market.